2022-2023 EVENTS

2022 Events

28 Aug - 01 Sep 2022
The International Surgical Week (ISW)
Kuala Lumpur

31 Aug – 2 Sept 2022
Medical Fair Asia
Marina Bay Sands, Singapore

3-9 September
Medical Fair Asia
Digital, Online

9-10 September 2022
World Pediatrics Conference
Bangkok, Thailand

9-10 September 2022
World Heart and Cardiothoracic Surgery Conference
Bangkok, Thailand

19-21 September 2022
23rd SE-Asian Healthcare & Pharma Show
Kuala Lumpur

27-29 September 2022
Smart Healthcare Expo (Health Malaysia)

27-29 September 2022
Asia Pandemic Congress
Kuala Lumpur Convention Centre

19-20 September 2022
23nd Global Nursing Education Conference
Brisbane, Australia

30 Sep - 2 Oct 2022
Malaysia International Dental Show (MIDS)
Sunway Pyramid Convention Centre, Subang Jaya, Malaysia

7-9 November 2022
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center

7-9 November 2022
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center

11-13 November 2022
Eldercare Exhibition and Conference Asia (ELDEX Asia 2022)
Suntex Singapore Exhibition and Convention Centre

14-15 November 2022
Healthcare Asia Pacific
Osaka, Japan

2023 Events

30 May – 1 June 2023
KL Convention Centre, Kuala Lumpur

13-15 September 2023
Medical Fair Thailand
BITEC, Bangkok

Free counters!


Health director-general Dr Noor Hisham Abdullah has sought to allay fears of a link between Pfizer’s bivalent vaccine and strokes in senior citizens.

Noor Hisham said a recent Reuters report was based on information from the US Food and Drug Administration and the US Centers for Disease Control and Prevention (CDC) about a safety signal that was detected from one of its safety monitoring databases.

On Friday, the agencies said CDC’s Vaccine Safety Datalink database uncovered a possible safety issue in which people 65 years and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer bivalent shot compared with days 22 to 44.

An ischemic stroke is caused by blockages in arteries that carry blood to the brain.

“All safety signals that are detected need to be investigated and evaluated first before being confirmed,” said Noor Hisham in a statement today.

“So far, no ischemic stroke safety signals were detected through other safety monitoring systems in the US, such as the Vaccine Adverse Event Reporting System, following the use of the Pfizer bivalent vaccine.

“Further analysis also did not confirm the safety signal. Safety monitoring of the (Pfizer Covid-19 bivalent) vaccine in other reference countries also did not detect this issue.”

Pfizer’s bivalent vaccines were granted conditional approval in Malaysia by the Drug Control Authority on Dec 13, with the public expected to have access to them by the end of this month.

Noor Hisham said that based on data submitted to the National Pharmaceutical Regulatory Agency (NPRA) by the company that holds the product registration for Pfizer’s bivalent vaccine in Malaysia, Pfizer Sdn Bhd, there have been no reported cases of stroke in the clinical studies conducted.

He said NPRA is keeping tabs on the data and analysis regarding the use of the bivalent vaccine in other countries.

Bivalent vaccines are essentially an upgraded version of Covid-19 vaccines and are aimed at providing improved protection against new subvariants.

The early vaccines were monovalent, meaning they only contained the spike protein of the original SARS-CoV-2 virus.

The new bivalent vaccines contain the spike protein of the original strain and also those of the Omicron subvariants BA.1 and BA.4-5. – FMT